Adithya Hande: India’s Silent Killer and a Scientific Breakthrough
Adithya Hande, Head of Clinical Projects at DERBI Foundation, shared a post on LinkedIn:
”India’s Silent Killer — and a Scientific Breakthrough You Need to Know About
Thrombosis-related diseases (like pulmonary embolism, stroke, and DVT) are quietly responsible for millions of hospitalizations and deaths in India each year — especially post-COVID.
Yet, we’re still relying on decades-old anticoagulants with dangerous side effects like internal bleeding and poor patient adherence.
But what if we could prevent clots safely, without disrupting the body’s natural healing?
Scientists at IISc have developed a game-changing nanozyme that mimics antioxidant enzymes — a first-of-its-kind, bleeding-free clot therapy.
This article dives into:
- What makes this science revolutionary
- The current treatment challenges for thrombosis in India
- Market gaps ripe for startup innovation
- Why this could be a deeptech goldmine for healthcare entrepreneurs
Click below to read the full breakdown — from a healthcare innovation lens.”
Stay updated with Hemostasis Today.
-
Jan 5, 2026, 15:33Mona Ahmed on Why Some Calcified Nodules Trigger ACS and Others Do Not
-
Jan 5, 2026, 14:17Abdul Mannan – VWF:RCo for Diagnosing von Willebrand Disease: That Test Might Be Failing Your Patients
-
Jan 5, 2026, 13:57Ewang Yemi: CAD is Real and Dangerous – Keep Your Heart Beating
-
Jan 5, 2026, 13:42Dr. Martha Boeckenfeld Shares VetiGel Creation Experiment: How A 17-Year-Old Mixed Algae in a Small Hidden Lab
-
Jan 5, 2026, 12:55Chokri Ben Lamine Explains Washed PRBCs!
-
Jan 5, 2026, 12:30ASH: Be Part of The Next Cohort of Hematology Quality Improvement Leaders
-
Jan 5, 2026, 09:59WFH Released New Evidence-Based Guidelines on AAV Gene Therapy for Hemophilia
-
Jan 5, 2026, 09:51Pete Stibbs: We Still Tend to Talk About VTE Like It’s a Plumbing Problem
-
Jan 5, 2026, 09:40Christopher Pittman on Treating Varicose Veins Before Knee or Hip Replacement